Sigyn Therapeutics, Inc. (SIGY) stock
SIGYOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.03+0.00 (0.00%)
Close on Oct 19, 2026Market cap $48.16KP/E –Yield –
Sigyn Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Sigyn Therapeutics's profit margin for the twelve months ending Sep 30, 2020 was -37071.5%. For fiscal 2019 it was -2145.3%, against -9243.2% the year before. The highest annual figure on record is -898.0% in fiscal 2014.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | -2145.3% | +7097.9 |
| FY2018 | Dec 31, 2018 | -9243.2% | +1818.0 |
| FY2017 | Dec 31, 2017 | -11061.2% | −1836.3 |
| FY2015 | Dec 31, 2015 | -9224.9% | −8326.8 |
| FY2014 | Dec 31, 2014 | -898.0% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2020 | Sep 30, 2020 | -7720.1% | −7538.5 |
| Q1 FY2020 | Mar 31, 2020 | -33225.1% | −33355.0 |
| Q4 FY2019 | Dec 31, 2019 | -53816.4% | −53422.8 |
| Q3 FY2019 | Sep 30, 2019 | -431.7% | +4893.7 |
| Q2 FY2019 | Jun 30, 2019 | -181.6% | +3012.5 |
| Q1 FY2019 | Mar 31, 2019 | 129.9% | +715.0 |
| Q3 FY2018 | Sep 30, 2018 | -393.6% | −169.9 |
| Q2 FY2018 | Jun 30, 2018 | -5325.4% | −5097.2 |
| Q1 FY2018 | Mar 31, 2018 | -3194.1% | – |
| Q3 FY2017 | Sep 30, 2017 | -585.1% | – |
| Q2 FY2017 | Jun 30, 2017 | -223.7% | – |
| Q1 FY2017 | Mar 31, 2017 | -228.3% | – |
See a number that looks wrong?